DJIA 17,086.63 -26.91 -0.16%
NASDAQ 4,473.70 17.68 0.40%
S&P 500 1,987.01 3.48 0.18%
market minute promo


9.66 0.06 (0.63%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

PDLI $9.66 0.63%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $9.66
Previous Close $9.60
Daily Range $9.63 - $9.75
52-Week Range $7.38 - $10.21
Market Cap $1.6B
P/E Ratio 5.52
Dividend (Yield) $0.60 (6.3%)
Ex-Dividend Date
Dividend Pay Date
Volume 2,479,111
Average Daily Volume 2,053,204
Current FY EPS $2.22





PDL BioPharma (PDLI) Description

A biopharmaceutical company focused on discovering, developing and commercializing innovative therapies for severe or life-threatening illnesses. Website:

News & Commentary

2 Health Care Partnerships Go Head-To-Head

While the partnership between GlaxoSmithKline (NYSE: GSK) and Ligand (NASDAQ: LGND) seems to be moving forward, the partnership between Roche (OTCMKTS: RHHBY) and PDL (NASDAQ: PDLI) has seemingly reached its end

Best High-Yielding Stocks According To Greenblatt Principles: PDL BioPharma

Top 4 NASDAQ Stocks In The Biotechnology Industry With The Lowest PEG Ratio

Buy-Rated Dividend Stocks: Top 3 Companies: ETR, PDLI, T

PDL BioPharma: Panning For Dividend Gold

PDL BioPharma Views Lower Q2 Revenues - Analyst Blog

Top 3 Yielding Buy-Rated Stocks: LHO, MPW, PDLI

Ex-Dividends For June 3, 2014

Dividend Watch: 3 Stocks Going Ex-Dividend Tomorrow: ERF, ARP, PDLI

PDL BioPharma, Inc. (PDLI) Ex-Dividend Date Scheduled for June 03, 2014

PDL BioPharma: Bringing In Assets, Generous Dividend And Cheap Valuations Add To Upside

See More PDLI News...

PDLI's Top Competitors

PDLI $9.66 (0.63%)
Current stock: PDLI
AMGN $122.01 (0.74%)
Current stock: AMGN
GILD $90.34 (1.13%)
Current stock: GILD
BIIB $337.60 (11.17%)
Current stock: BIIB